Similar articles

• Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle.

  Mostad SB, Jackson S, Overbaugh J, Reilly M, Chohan B, Mandaliya K, Nyange P, Ndinya-Achola J, Bwayo JJ, Kreiss JK. Mostad SB, et al. J Infect Dis. 1998 Oct;178(4):983-91. doi: 10.1086/515665. J Infect Dis. 1998. PMID: 9806025
• Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract.

  Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, Carpenter CC; HIV Epidemiology Research Study. Cu-Uvin S, et al. Clin Infect Dis. 2001 Sep 15;33(6):894-6. doi: 10.1086/322613. Epub 2001 Aug 10. Clin Infect Dis. 2001. PMID: 11512096
• Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.

  Coombs RW, Wright DJ, Reichelderfer PS, Burns DN, Cohn J, Cu-Uvin S, Baron PA, Cohen MH, Landay AL, Lewis S, Kovacs A; Women's Health Study 001 Team. Coombs RW, et al. J Infect Dis. 2001 Nov 1;184(9):1187-91. doi: 10.1086/323660. Epub 2001 Sep 13. J Infect Dis. 2001. PMID: 11598843
• Overview on source of the virus, viral measurement and variability.

  Coombs RW. Coombs RW. J Acquir Immune Defic Syndr. 2005 Mar;38 Suppl 1:S31-2. doi: 10.1097/01.qai.0000167038.50558.69. J Acquir Immune Defic Syndr. 2005. PMID: 15867613 Review. No abstract available.
• Effect of pregnancy.

  Watts DH. Watts DH. J Acquir Immune Defic Syndr. 2005 Mar;38 Suppl 1:S36-8. doi: 10.1097/01.qai.0000167041.35311.be. J Acquir Immune Defic Syndr. 2005. PMID: 15867616 Review. No abstract available.